# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Marilyn Monroe (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML002-SYN
- Date: 2026-06-15
- Fictional facility: St. Posthumous Health Center
- Fictional author: Joanna Whitlock, MD
- Calendar frame: modern shifted

## Reason for visit

New patient with severe painful periods and pelvic pain: history and pelvic examination, suspected endometriosis, first-line hormonal and anti-inflammatory treatment, a pain plan without opioids or sedatives, and a depression and anxiety screen. **S**

## Historical basis

- She was born Norma Jeane Mortenson on June 1, 1926, at Los Angeles General Hospital. Her father's identity is unconfirmed; her mother was often confined to asylums, and she spent her childhood in orphanages and foster homes. **D**
- She worked as a photographic model, signed with Twentieth Century-Fox in 1946 under the name Marilyn Monroe, starred in films of the 1950s including Gentlemen Prefer Blondes and The Seven Year Itch, and studied at the Actors Studio in the mid-1950s. **D**
- Her mother, Gladys, was diagnosed with paranoid schizophrenia and was institutionalized, for the first time at the state hospital in Norwalk. **D**
- She is described as one of the most famous people with endometriosis. Her biographer Anthony Summers wrote that the condition was so severe that it destroyed her marriages, her wish for children, her career and ultimately her life; a review of endometriosis for clinicians quotes this account, and museum and medical-history writers list endometriosis among her health problems. **D**
- The same biographical account holds that, in the days before effective conservative surgery or medical therapy, her endometriosis led to progressively increasing use of strong analgesics, tranquilizers and hypnotics, and to drug dependency. **R**
- The physician and historian Howard Markel writes that she had several mental health problems, including substance abuse, depression and, most likely, bipolar disorder, as well as endometriosis and gall bladder disease. **R**
- Most of the drugs she misused had been prescribed to her by physicians; they included the barbiturate Nembutal and chloral hydrate. **D**
- A retrospective psychological autopsy based on biographies, films and her writings proposes autism spectrum traits progressing to borderline personality disorder and bipolar disorder; the roster lists borderline personality disorder and depression. **R**

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- Her periods are so painful that she misses work, and she wants to know what is wrong. **S**
- She wants children one day and is afraid that the cause of her pain, or an operation, will prevent it. **S**
- She feels low and sleeps badly on painful nights, and does not want to depend on pills. **S**

## Strengths and supports

- Supports: her partner, a close friend from acting class, and her drama coach; reading and acting class steady her. She decides who is told about her health **S**

## Medications and allergies

- Naproxen 500 mg oral tablet, one tablet by mouth twice daily with food, from two days before an expected bleed until the third day, and for pain flares; no more than 10 days a month **S**
- Ethinyl estradiol 0.02 mg and norethindrone acetate 1 mg oral tablet, one tablet by mouth daily, taken continuously without a pill-free week **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- No historical medical events recorded.

## Procedures and immunizations

- No procedures before this visit. **S**


## Family history

- mother: Diagnosed with paranoid schizophrenia and institutionalized **D** (CLM-0003)

## Measurements

White cells: 6.4 10*3/uL; Hemoglobin: 12.2 g/dL; Platelets: 262 10*3/uL; PHQ-9: 12; GAD-7: 8; Pelvic pain, worst in the past week (0 to 10): 8. All results are synthetic.

BP 112/70 mmHg; pulse 76 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 99% on room air; weight 56 kg; BMI 20.3 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert, warm and cooperative; speech normal; thought process organized; no psychotic features; no history of manic or hypomanic episodes; Mood low, worse in the days around her period; tearful when describing missed work; PHQ-9 score 12 with item 9 scored 0; GAD-7 8; no thoughts of suicide or self-harm, now or in the past. Functional status: Independent; in bed for one or two days each period; walks most days when she is not in pain. Physical examination is intentionally limited. **S**

## Safety assessment

Current ideation: absent; intent: absent; plan: absent; access reviewed: yes. Disposition: Outpatient care. She has no thoughts of suicide or self-harm now and has never had them. Because pain, poor sleep and a moderate depressive episode raise risk, a brief written safety plan was made with her, with warning signs (feeling hopeless, not sleeping for nights at a time, wanting to use medicines to blot out the day) and what to do about each. Lethal-means counseling: no firearm at home; leftover medicines are to be returned to a pharmacy take-back site, and no opioid, benzodiazepine or sleep medicine will be prescribed. The 988 Suicide & Crisis Lifeline was given and saved in her phone, with the clinic number. Safety reviewed at every visit. This is synthetic and does not convert historical behavior into a current finding. **S**

## Assessment

1. Severe painful periods since her teens, worse over the past three years, with pelvic pain between periods, deep pain with intercourse, and painful bowel movements during periods; she misses work for two or three days each cycle. Tender, slightly fixed retroverted uterus with tenderness and fullness in the left adnexa and along the left uterosacral ligament. Suspected endometriosis; transvaginal ultrasound and gynecology consultation booked; status draft. **S**
2. Major depressive disorder, single episode, moderate: about two months of low mood, poor sleep on painful nights, low energy, guilt about missed work, and poor concentration (PHQ-9 12, item 9 scored 0; GAD-7 8); Mood Disorder Questionnaire negative; no thoughts of suicide or self-harm; status draft. **S**

## Plan

- First-line treatment for suspected endometriosis without waiting for a diagnosis: naproxen with food for pain days, and a combined estrogen and progestin pill taken continuously to stop the periods, after a negative pregnancy test and a check for reasons to avoid estrogen (migraine with aura, smoking over 35, clotting history, high blood pressure). Guideline: Practice Bulletin No. 114: Management of Endometriosis (2010); ESHRE guideline: endometriosis (2022); U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 (2024) **S**
- Gynecology consultation for suspected endometriosis: diagnosis, the role and timing of surgery, and fertility counseling for a woman who wants children. Guideline: Practice Bulletin No. 114: Management of Endometriosis (2010); ESHRE guideline: endometriosis (2022) **S**
- Transvaginal ultrasound by an experienced sonographer, looking for endometriomas and deep nodules; CA-125 not used to diagnose endometriosis; gonorrhea and chlamydia tests and a urinalysis to exclude other causes. Guideline: ESHRE guideline: endometriosis (2022); Chronic Pelvic Pain: ACOG Practice Bulletin, Number 218 (2020) **S**
- A pain plan that avoids opioid and sedative accumulation: no opioid, benzodiazepine or sleep-medicine prescription, the prescription monitoring program checked, diphenhydramine stopped, leftover medicines returned, heat and regular walking, and cognitive behavioral therapy for insomnia. Guideline: Chronic Pelvic Pain: ACOG Practice Bulletin, Number 218 (2020); CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022) **S**
- Depression care: cognitive behavioral therapy with the clinic's behavioral health clinician, the PHQ-9 and GAD-7 at each visit, an antidepressant to be discussed if the PHQ-9 has not fallen by half at eight to twelve weeks, a structured safety assessment and plan, the 988 Suicide & Crisis Lifeline, and safety review at every visit. Guideline: Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**

## Guideline basis

- Practice Bulletin No. 114: Management of Endometriosis (2010), American College of Obstetricians and Gynecologists (Obstetrics and Gynecology)
- ESHRE guideline: endometriosis (2022), European Society of Human Reproduction and Embryology (Human Reproduction Open)
- Chronic Pelvic Pain: ACOG Practice Bulletin, Number 218 (2020), American College of Obstetricians and Gynecologists (Obstetrics and Gynecology)
- CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022), Centers for Disease Control and Prevention (MMWR Recommendations and Reports)
- U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 (2024), Centers for Disease Control and Prevention (MMWR Recommendations and Reports)
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge
